1.  Explain the indications and contraindications to the NuPulse iVAS for long-term-support for patients with heart failure

2. Compare demonstrated outcomes for patients with the NuPulse iVAS versus other treatment modalities.

3. Assess the evolution of and current state of VAD devices and hypothesize future potential areas for innovation. 


Session date: 
04/17/2018 - 6:45am to 7:45am CDT
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Valluvan Jeevanandam, MD